Cell Biology International
暂无分享,去创建一个
Qi Zhou | Ling Tao | Xiyan Wang | Xi-yan Wang | Qi Zhou
[1] S. Ghorbian,et al. Long non-coding RNAs and cervical cancer. , 2019, Experimental and molecular pathology.
[2] Y. Ye,et al. LncRNA SNHG16 predicts poor prognosis in ESCC and promotes cell proliferation and invasion by regulating Wnt/β-catenin signaling pathway. , 2018, European review for medical and pharmacological sciences.
[3] S. Gu,et al. Transcription factor PU.1 is involved in the progression of glioma , 2018, Oncology letters.
[4] Jun Liu,et al. MiR-216b inhibits cell proliferation by targeting FOXM1 in cervical cancer cells and is associated with better prognosis , 2017, BMC Cancer.
[5] Man-man Su,et al. Long non-coding RNAs on the stage of cervical cancer (Review). , 2017, Oncology reports.
[6] Q. Shang,et al. Effects of DCK knockdown on proliferation, apoptosis and tumorigenicity in vivo of cervical cancer HeLa cells , 2017, Cancer Gene Therapy.
[7] J. Vider,et al. MicroRNA‐186‐5p overexpression modulates colon cancer growth by repressing the expression of the FAM134B tumour inhibitor , 2017, Experimental cell research.
[8] H. Kitchener,et al. Cervical cancer: A global health crisis , 2017, Cancer.
[9] Yan Wang,et al. Long Noncoding RNA ANRIL Promotes Cervical Cancer Development by Acting as a Sponge of miR-186. , 2017, Oncology research.
[10] Steven J. M. Jones,et al. Integrated genomic and molecular characterization of cervical cancer , 2017, Nature.
[11] Jakob Skou Pedersen,et al. SNHG16 is regulated by the Wnt pathway in colorectal cancer and affects genes involved in lipid metabolism , 2016, Molecular oncology.
[12] Kathryn E. Hentges,et al. Transcriptional regulation of the proto‐oncogene Zfp521 by SPI1 (PU.1) and HOXC13 , 2016, Genesis.
[13] C. Peterson,et al. A somatic mutation of GFI1B identified in leukemia alters cell fate via a SPI1 (PU.1) centered genetic regulatory network. , 2016, Developmental biology.
[14] M. Hottiger. Poly(ADP-ribose) polymerase inhibitor therapeutic effect: are we just scratching the surface? , 2015, Expert opinion on therapeutic targets.
[15] Jun S. Liu,et al. Inference of transcriptional regulation in cancers , 2015, Proceedings of the National Academy of Sciences.
[16] Sejal Vyas,et al. New PARP targets for cancer therapy , 2014, Nature Reviews Cancer.
[17] Sejal Vyas,et al. A systematic analysis of the PARP protein family identifies new functions critical for cell physiology , 2013, Nature Communications.
[18] A. Seth,et al. ETS transcription factors and their emerging roles in human cancer. , 2005, European journal of cancer.
[19] A. Albor,et al. Regulation of the human poly(ADP-ribose) polymerase promoter by the ETS transcription factor , 1999, Oncogene.
[20] A. Boyles,et al. National Institute of Environmental Health Sciences , 2008 .
[21] K. Su,et al. A novel positive feedback regulation between long noncoding RNA UICC and IL-6/STAT3 signaling promotes cervical cancer progression. , 2018, American journal of cancer research.
[22] H. Hua,et al. PARP 9 is overexpressed in human breast cancer and promotes cancer cell migration , 2018 .
[23] Hong Zhu,et al. SNHG16/miR-216-5p/ZEB1 signal pathway contributes to the tumorigenesis of cervical cancer cells. , 2018, Archives of biochemistry and biophysics.
[24] Yi Feng,et al. Long Non-Coding RNAs , 2016, Methods in Molecular Biology.